The HDAC2-DNMT3B-Bcl2 axis in gliomas is differentially expressed and interacting, HDAC2 activates the transcriptional activity of DNMT3B, and DNMT3B inhibits the expression of Bcl2. This evidence concerns the gene HDAC2 and central nervous system cancer.